CARVEDILOL | A076649 | RISING PHARMA HOLDINGS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Reference 3 Pharmacokinetic Properties of a New Controlled-Release Formulatio... FDA-2020-P-2166 Emprise Pharma LLC, on behalf of New Time Pharmaceutical Co, Ltd, filed a petition regarding the pharmacokinetic properties and suitability of a new controlled-release formulation of carvedilol. The petitioner sought FDA guidance or determination on whether the proposed controlled-release formulatio | Suitability | 2020-11-05 | Open | Emprise Pharma LLC |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.